Creutzfeldt-Jakob disease MRI: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}
==Overview==
==Overview==
MRI findings in CJD include high signal abnormalities in [[caudate nucleus]] and/or [[putamen]] on diffusion-weighted imaging (DWI) or fluid attenuated inversion recovery (FLAIR).<ref name="www.cdc.gov">{{Cite web  | last =  | first =  | title = http://www.cdc.gov/ncidod/dvrd/cjd/diagnostic_criteria.html | url = http://www.cdc.gov/ncidod/dvrd/cjd/diagnostic_criteria.html | publisher =  | date =  | accessdate = 17 February 2014 }}</ref>
MRI findings in CJD include high signal abnormalities in [[caudate nucleus]] and/or [[putamen]] on diffusion-weighted imaging (DWI) or fluid attenuated inversion recovery (FLAIR).<ref name="www.cdc.gov">{{Cite web  | last =  | first =  | title = http://www.cdc.gov/ncidod/dvrd/cjd/diagnostic_criteria.html | url = http://www.cdc.gov/ncidod/dvrd/cjd/diagnostic_criteria.html | publisher =  | date =  | accessdate = 17 February 2014 }}</ref> Additional findings on diffusion weighted imaging include cortical, subcortical, and thalamic involvement.


== MRI==
== MRI==
* MRI often shows high signal intensity in the [[caudate nucleus]] and [[putamen]] bilaterally on T2-weighted images.
* MRI often shows high signal intensity in the [[caudate nucleus]] and [[putamen]] bilaterally on T2-weighted images.
* [[Diffusion Weighted Imaging]] (DWI) images are the most sensitive.  In about 24% of cases, DWI showed only cortical hyperintensity, cortical and subcortical abnormalities were shown in 68% of cases and in 5%, only subcortical anomalies were present.<ref>{{cite journal|last= Young|first= Geoffrey S.|coauthors= Michael D. Geschwind, Nancy J. Fischbein, Jennifer L. Martindale, Roland G. Henry, Songling Liu, Ying Lu, Stephen Wong, Hong Liu, Bruce L. Miller and William P. Dillon|title=Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Imaging in Creutzfeldt-Jakob Disease: High Sensitivity and Specificity for Diagnosis|journal=American Journal of Neuroradiology|volume= 26|pages=1551-1562|date=June-July 2005|publisher=American Society of Neuroradiology|url=http://www.ajnr.org/cgi/content/full/26/6/1551|accessdate =  2007-10-30}}</ref>
* [[Diffusion Weighted Imaging]] (DWI) images may be remarkable for the following findings:<ref>{{cite journal|last= Young|first= Geoffrey S.|coauthors= Michael D. Geschwind, Nancy J. Fischbein, Jennifer L. Martindale, Roland G. Henry, Songling Liu, Ying Lu, Stephen Wong, Hong Liu, Bruce L. Miller and William P. Dillon|title=Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Imaging in Creutzfeldt-Jakob Disease: High Sensitivity and Specificity for Diagnosis|journal=American Journal of Neuroradiology|volume= 26|pages=1551-1562|date=June-July 2005|publisher=American Society of Neuroradiology|url=http://www.ajnr.org/cgi/content/full/26/6/1551|accessdate =  2007-10-30}}</ref>
* The involvement of the [[thalamus]] can be found in sCJD and is even stronger and constant in [[vCJD]].<ref>{{cite journal  | last =Tschampa  | first =Henriette J.  |authorlink =  | coauthors =Petra Mürtz, Sebastian Flacke, Sebastian Paus, Hans H. Schild and Horst Urbach  | title =Thalamic Involvement in Sporadic Creutzfeldt-Jakob Disease: A Diffusion-Weighted MR Imaging Study  | journal =American Journal of Neuroradiology  | volume =24  | pages =908-915  | publisher =American Society of Neuroradiology  |date=May 2003  | url =http://www.ajnr.org/cgi/content/full/24/5/908  | accessdate =  2007-10-30}}</ref>
:*Cortical hyperintensity (25%-70% of cases)
* An abnormal signal in the posterior thalami on T2- and diffusion-weighted images and fluid-attenuated inversion recovery sequences on brain magnetic resonance imaging (MRI); in the appropriate clinical context, this signal is highly specific for [[vCJD]].
:*Subcortical abnormalities (5% of cases)
:*Thalamic involvement, usually in posterior thalamus (more strongly associated with variant Creutzfeldt-Jakob disease than with classic Creutzfeldt-Jakob disease)<ref>{{cite journal  | last =Tschampa  | first =Henriette J.  |authorlink =  | coauthors =Petra Mürtz, Sebastian Flacke, Sebastian Paus, Hans H. Schild and Horst Urbach  | title =Thalamic Involvement in Sporadic Creutzfeldt-Jakob Disease: A Diffusion-Weighted MR Imaging Study  | journal =American Journal of Neuroradiology  | volume =24  | pages =908-915  | publisher =American Society of Neuroradiology  |date=May 2003  | url =http://www.ajnr.org/cgi/content/full/24/5/908  | accessdate =  2007-10-30}}</ref>


==References==
==References==
Line 16: Line 17:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Transmissible spongiform encephalopathies]]
[[Category:Transmissible spongiform encephalopathies]]
[[Category:Needs overview]]

Revision as of 20:17, 22 March 2016

Creutzfeldt-Jakob disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Creutzfeldt-Jakob disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Creutzfeldt-Jakob disease MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Creutzfeldt-Jakob disease MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Creutzfeldt-Jakob disease MRI

CDC on Creutzfeldt-Jakob disease MRI

Creutzfeldt-Jakob disease MRI in the news

Blogs on Creutzfeldt-Jakob disease MRI

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Creutzfeldt-Jakob disease MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

MRI findings in CJD include high signal abnormalities in caudate nucleus and/or putamen on diffusion-weighted imaging (DWI) or fluid attenuated inversion recovery (FLAIR).[1] Additional findings on diffusion weighted imaging include cortical, subcortical, and thalamic involvement.

MRI

  • Cortical hyperintensity (25%-70% of cases)
  • Subcortical abnormalities (5% of cases)
  • Thalamic involvement, usually in posterior thalamus (more strongly associated with variant Creutzfeldt-Jakob disease than with classic Creutzfeldt-Jakob disease)[3]

References

  1. "http://www.cdc.gov/ncidod/dvrd/cjd/diagnostic_criteria.html". Retrieved 17 February 2014. External link in |title= (help)
  2. Young, Geoffrey S. (June–July 2005). "Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Imaging in Creutzfeldt-Jakob Disease: High Sensitivity and Specificity for Diagnosis". American Journal of Neuroradiology. American Society of Neuroradiology. 26: 1551–1562. Retrieved 2007-10-30. Unknown parameter |coauthors= ignored (help)
  3. Tschampa, Henriette J. (May 2003). "Thalamic Involvement in Sporadic Creutzfeldt-Jakob Disease: A Diffusion-Weighted MR Imaging Study". American Journal of Neuroradiology. American Society of Neuroradiology. 24: 908–915. Retrieved 2007-10-30. Unknown parameter |coauthors= ignored (help)


Template:WikiDoc Sources